Black Diamond Therapeutics, Inc.BDTXNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$29.61M
↑ 171% vs avg
Percentile
P100
Near historical high
Streak
4 yr
Consecutive growthExpanding
Average
$-41.72M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $29.61M | +147.5% |
| 2024 | $-62.30M | +6.7% |
| 2023 | $-66.75M | +21.7% |
| 2022 | $-85.27M | +17.1% |
| 2021 | $-102.86M | -96.7% |
| 2020 | $-52.29M | -111.7% |
| 2019 | $-24.70M | -189.5% |
| 2018 | $-8.53M | -251.3% |
| 2017 | $-2.43M | - |